Preliminary Q4 2025 Primary Health Properties PLC Earnings Call Transcript
Key Points
- Primary Health Properties PLC (PHPRF) reported a 4% growth in adjusted earnings per share, with a fully covered dividend, marking the 30th consecutive year of dividend growth.
- The company completed a transformational merger with Assura PLC, leading to significant strategic and financial benefits, including a GBP48 million valuation gain.
- The integration of Assura is ahead of schedule, with over 80% of cost synergies (GBP7.5 million) already delivered.
- The company has a strong portfolio with 99% occupancy and an 11-year WAULT, with 80% of recurring income from government-backed occupiers.
- Primary Health Properties PLC (PHPRF) is making progress in joint ventures, with a GBP103 million transaction expected to complete in Q2 2026, enhancing its capital efficiency and growth potential.
- The EPRA net asset value per share was reduced due to one-off transaction costs and the share exchange ratio from the Assura merger.
- The company's LTV stands at 57%, above the target range of 40% to 50%, indicating a need for deleveraging.
- The net debt-to-EBITDA ratio is just over 10 times, exceeding the target of below 9.5 times.
- There are concerns about the impact of geopolitical events on negotiations for the private hospital joint venture.
- The company faces challenges in maintaining its government-backed income target, currently at 76%, below the 80% to 90% target range.
Good morning. Thank you for joining us. We are here today at a very exciting time for our company, on the day of publishing a very strong set of results. We recently completed a transformational merger with Assura PLC, in a short space of time have made great progress delivering the strategic and financial benefits of this transaction.
Since our well-received trading update on the 13th of January, we've made further progress on our strategic priorities. I'll bring you up to date on that today, plus share with you our well progressed discussions with joint venture partners on our primary care and private hospital assets.
You will also see from our presentation later, there are a number of positive learnings from our enlarged portfolio review. And the further upside we can see will deliver value in the future. This has been a transformational year, and this is a strong set of results.
I've already alluded to the positive impact of the combination with Assura. And I'm delighted to say that
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
